EU drug regulator recommends Pfizer COVID vaccine for kids

• They cited a study in children ages 5 to 11 that found the vaccine to be 90.7% effective at preventing symptomatic COVID-19.
• The recommendation will be sent to the European Commission, which will issue a final decision.

The big picture: The announcement comes after the CDC earlier this month recommended Pfizer shots for kids of the same age group.

What to watch: Pfizer and BioNTech said they have submitted requests for authorization of their COVID-19 vaccine for kids to other regulators around the world.

• The companies say they also expect initial pivotal data from their ongoing clinical trial in children 2 to 5 years old this quarter and in kids aged 6 months to 2 years in the first quarter of 2022.